Relationship Between Nectin-4-Positive Exosomes in Blood and Urine and the Response to Enfortumab Vedotin Therapy

Overview

About this study

The purpose of this study is to assess the relationship between Nectin-4-positive exosomes in blood and urine and the response to Enfortumab vedotin therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults aged 18 years or older.
Confirmed diagnosis of urothelial cancer.
Scheduled to initiate Enfortumab vedotin therapy.
Willing and able to provide informed consent.

Exclusion Criteria:

Inability or unwillingness to provide informed consent.
Contraindications to Enfortumab vedotin therapy.
Any medical condition or treatment that, in the investigator's judgment, would interfere with the study's objectives.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 9/21/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Jacob Orme, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Orme, M.D., Ph.D.

Closed-enrolling by invitation

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Clinical Trials